Factbox-Companies in Alzheimer’s race after US nod for Eisai/Biogen drug
(Reuters) – Eisai Co Ltd and Biogen Inc’s Leqembi emerged as the first Alzheimer’s treatment to win the U.S. Food and Drug Administration’s standard approval on Thursday, a milestone in…